Hydrogel is a water-insoluble polymer chain network that provides moist wound surface owing to high water content (90% water in the gel base). Hydrogel dressing is an essential component in wound care as its high moisture content helps prevent the infections by obstructing microorganisms. It holds moisture on the surface of a wound, which helps in pain management and provides an ideal environment for wound cleansing of autolytic debridement. Hydrogel dressing is used for dry, necrotic wounds, sloughy, granulating and epithelializing wound care. They are also used for the surgical wounds, skin tears, burns, pressure ulcers, and diabetes-related wounds.
The U.S. hydrogel dressing market is estimated to generate $258 million by 2022, with a CAGR of 7.0% from 2016 to 2022. The increasing incidence of diabetic patients with clotting disorders and increasing number of accidental emergencies, especially burn injuries, led to the substantial requirement of hydrogel dressings for wound care. In addition, increasing adoption of hydrogel dressings as a substitute for traditional gauze for wound care applications is one of the key drivers of the market. Moreover, technological innovation in wound closure techniques, namely, injectable stimuli-responsive amorphous hydrogels for stopping bleeding in trauma cases and military personnel, further supplement the market growth. On the contrary, factors restricting the market growth are the high costs associated with the manufacture of hydrogel dressings and long lab to market pipeline period for healthcare products.
This report segments the U.S. hydrogel dressing market on the basis of product type into amorphous hydrogel dressing, impregnated gauze, and hydrogel sheets. Amorphous hydrogel dressing emerged as the leading segment, accounting for close to one half of the overall market in 2015 and is estimated to maintain the lead during the forecast period. The demand for amorphous hydrogel dressing rises with increasing awareness about the product and its benefits.
Key market players, such as 3M Company and Johnson & Johnson, adopt capacity addition and promotion of the benefits of the product over traditional wound closure products as their key strategies. Recent advancement in chitosan hydrogel with human amniotic membrane has increased the scope of hydrogel dressing in tissue engineering and regeneration. In the year 2013, scientists successfully tested the amniotic membrane extracts (AME) and chitosan hydrogel dressing, also known as biological dressings, for treatment of partial burns. The key reason for the development of these dressings is that they provide improved healing results when compared to single-layered conventional wound dressing systems.
KEY BENEFITS FOR STAKEHOLDERS:
- This report provides an extensive analysis of the current trends and emerging estimations and dynamics in the global U.S. hydrogel dressing market.
- The market scenario is comprehensively analyzed in accordance to the key product types.
- The market estimations are based on high-end analysis of the key developments for the period of 2015–2022.
- Extensive research is done by product type, which instils a clear understanding regarding the current trends.
- Recent developments, key manufacturers, their market shares, and upcoming products have been listed to analyze the competitive scenario of the U.S. hydrogel dressing market.
- Scenario beyond 2022 till 2027 has been explained through contingent patterns based on moderate, rapid, and slow growth rates of the U.S. market.
HYDROGEL DRESSING MARKET KEY SEGMENTS:
The U.S. hydrogel dressing market segmentation is illustrated below:
- Amorphous hydrogel dressing
- Impregnated gauze
- Hydrogel sheets
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Secondary research
1.2 Primary research
1.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market snapshot
2.2 Market beyond: What to expect till 2027
2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Slow growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Top investment pockets
3.3 Porters five forces analysis
3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Threat of substitutes
3.3.5 Competitive rivalry
3.4 Market dynamics
22.214.171.124 Rising incidences of burn injuries, number of diabetics and trauma cases in the U.S.
126.96.36.199 Relatively complex process and high production cost
188.8.131.52 Research & developments through collaboration between research institutes and companies
3.5 Market share analysis
CHAPTER 4 U.S. HYDROGEL DRESSING MARKET
4.1 Key market trend
4.2 Market size and forecast
4.3 Amorphous hydrogel dressing
4.3.1 Key market trends
4.3.2 Market size and forecast
4.4 Impregnated gauze dressing
4.4.1 Key market trend
4.4.2 Market size and forecast
4.5 Hydrogel sheets
4.5.1 Key market trend
4.5.2 Market size and forecast
CHAPTER 5 COMPANY PROFILES
5.1 Alliqua Biomedical Inc.
5.1.1 Alliqua Biomedical Inc., Overview
5.1.2 Business performance
5.1.3 Key strategies and developments
184.108.40.206 Primary strategy
5.1.4 SWOT analysis
5.2 Procyon Corp. (A parent company for Amerx Health Care Corp.)
5.2.1 Procyon Corp. (Amerx Health Care Corp.) Overview
5.2.2 Business performance
5.2.3 SWOT analysis
5.3 BSN Medical GmbH (A parent company for BSN Medical Inc.)
5.3.1 BSN Medical GmbH (BSN Medical Inc.), Overview
5.3.2 Business performance
5.3.3 Key strategies and developments
220.127.116.11 Primary strategy
5.3.4 SWOT analysis
5.4 ConvaTec Healthcare B S.a.r.l. (A parent company for ConvaTec Inc.)
5.4.1 ConvaTec Healthcare B S.a.r.l.(ConvaTec Inc.), Overview
5.4.2 Business performance
5.4.3 Key strategies and developments
18.104.22.168 Primary strategy
5.4.4 SWOT analysis
5.5 ColoPlast A/S.
5.5.1 ColoPlast A/S., Overview
5.5.2 Business performance
5.5.3 SWOT analysis
5.6 Gentell Inc.
5.6.1 Gentell Inc., Overview
5.6.2 Key Strategies and developments
5.6.3 SWOT analysis
5.7 Smith & Nephew Plc.
5.7.1 Smith & Nephew Plc. Overview
5.7.2 Business performance
5.7.3 Key strategies and developments
5.7.4 SWOT analysis
5.8 3M Co.
5.8.1 3M Co. Overview
5.8.2 Business performance
5.8.3 Key strategies and developments
5.8.4 SWOT analysis
5.9 Axelgaard Manufacturing Co. Ltd
5.9.1 Axelgaard Manufacturing Co. Ltd. overview
5.9.2 Key strategies and developments
5.9.3 SWOT analysis
5.10 Johnson & Johnson
5.10.1 Company overview
5.10.1 Company snapshot
5.10.2 Business performance
5.10.3 Key strategies and developments
5.10.4 SWOT analysis of Johnson & Johnson
List of Figures
FIG. 1 TOP INVESTMENT POCKETS OF U.S. HYDROGEL DRESSINGS MARKET (2015-2022)
FIG. 2 PORTERS FIVE FORCES ANALYSIS
FIG. 3 NUMBER OF BURN VICTIMS IN THE U.S., 2011-2015
FIG. 4 MARKET SHARE ANALYSIS OF HYDROGEL DRESSING MARKET, 2015
FIG. 5 U.S. AMORPHOUS HYDROGEL DRESSING MARKET, 2015 - 2022
FIG. 6 U.S. IMPREGNATED GAUZE DRESSING MARKET, 2015 - 2022
FIG. 7 U.S. HYDROGEL SHEETS MARKET, 2015 - 2022
FIG. 8 ALLIQUA BIOMEDICAL INC., REVENUES BY YEARS
FIG. 9 ALLIQUA BIOMEDICAL INC., SHARE OF SALES BY BUSINESS SEGMENT, IN 2015 (%)
FIG. 10 SWOT ANALYSIS ALLIQUA BIOMEDICAL INC.
FIG. 11 PROCYON CORP. (AMERX HEALTH CARE CORP.), REVENUES BY YEARS
FIG. 12 SWOT ANALYSIS OF AMERX HEALTH CARE CORP.
FIG. 13 BSN MEDICAL GMBH (BSN MEDICAL INC.), REVENUES BY YEARS
FIG. 14 SWOT ANALYSIS OF BSN MEDICAL INC.
FIG. 15 CONVATEC HEALTHCARE B S.A.R.L. (CONVATEC INC.), REVENUES BY YEARS
FIG. 16 CONVATEC HEALTHCARE B S.A.R.L. (CONVATEC INC.), REVENUES FOR WOUND MANAGEMENT BY YEARS
FIG. 17 CONVATEC HEALTHCARE B S.A.R.L.(CONVATEC INC.), SALES BY BUSINESS SEGMENT IN 2014
FIG. 18 SWOT ANALYSIS - CONVATEC INC.
FIG. 19 COLOPLAST A/S, REVENUES BY YEARS
FIG. 20 SWOT ANALYSIS - COLOPLAST A/S.
FIG. 21 SWOT ANALYSIS OF GENTELL INC.
FIG. 22 SMITH & NEPHEW PLC., REVENUES BY YEAR ($MILLION)
FIG. 23 SMITH & NEPHEW PLC., REVENUE BREAKDOWN BY GEOGRAPHY, 2015 ($MILLION)
FIG. 24 SWOT ANALYSIS OF SMITH & NEPHEW PLC.
FIG. 25 3M CO. REVENUES BY YEAR ($MILLION)
FIG. 26 3M CO. REVENUES BY GEOGRAPHY PERCENTAGES, 2014
FIG. 27 3M CO. REVENUES BY BUSINESS SEGMENTS PERCENTAGES, 2014
FIG. 28 SWOT ANALYSIS OF 3M CO.
FIG. 29 SWOT ANALYSIS - AXELGAARD MANUFACTURING CO. LTD
FIG. 30 KEY FINANCIALS OF JOHNSON & JOHSNON $MILLION (2012-2014)
FIG. 31 FINANCIAL REVENUES BY SEGMENTS (2015)
FIG. 32 FINANCIAL REVENUES BY GEOGRAPHY (2014)
FIG. 33 SWOT ANALYSIS OF JOHNSON & JOHNSON
List of Table
TABLE 1 U.S. HYDROGEL DRESSING MARKET MODERATE GROWTH SCENARIO, BY TYPES, 2022 2027 ($MILLION)
TABLE 2 U.S. HYDROGEL DRESSING MARKET RAPID GROWTH SCENARIO, BY TYPES, 2022 2027 ($MILLION)
TABLE 3 U.S. HYDROGEL DRESSING MARKET SLOW GROWTH SCENARIO, BY TYPES, 2022 2027 ($MILLION)
TABLE 4 RECENT HYDROGEL PRODUCT LAUNCHES
TABLE 5 TYPE OF COMMERCIALLY AVAILABLE HYDROGEL DRESSINGS
TABLE 6 HYDROGEL PRODUCTS AND ITS MANUFACTURERS
TABLE 7 U.S. HYDROGEL DRESSING MARKET BY TYPES, 2015 - 2022 ($MILLION)
TABLE 8 HYDROGEL IMPREGNATED GAUZE PRODUCTS AND ITS MANUFACTURERS
TABLE 9 ALLIQUA BIOMEDICAL INC. SNAPSHOT
TABLE 10 PROCYON CORP. (AMERX HEALTH CARE CORP.) SNAPSHOT
TABLE 11 BSN MEDICAL GMBH (BSN MEICAL INC.), SNAPSHOT
TABLE 12 CONVATEC HEATHCARE B S.A.R.L. (CONVATEC INC.), SNAPSHOT
TABLE 13 COLOPLAST A/S., SNAPSHOT
TABLE 14 GENTELL INC., SNAPSHOT
TABLE 15 SMITH & NEPHEW PLC. SNAPSHOT
TABLE 16 3M CO. SNAPSHOT
TABLE 17 AXELGAARD MANUFACTURING CO. LTD SNAPSHOT
TABLE 18 JOHNSON & JOHNSON COMPANY SNAPSHOT